Semaglutide associated with lower opioid overdoses in people OUD and type 2 diabetes: JAMA Dr. Kamal Kant Kohli27 Sept 2024 9:00 AM ISTSince being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the...
Drugs not yet marketed in India, Submit PSUR Data: CDSCO Panel Tells Novo Nordisk on Semaglutide injection Dr. Divya Colin6 Aug 2024 6:00 PM ISTNew Delhi: Noting that proposed drug products Semaglutide Injection 0.25mg/0.5mg/1mg/1.7mg/2.4mg (Wegovy) and Semaglutide Injection...
Website unlawfully selling versions of Novo Nordisk weight loss drugs gets USFDA warning Ruchika Sharma3 July 2024 6:45 PM ISTThe U.S. Food and Drug Administration (USFDA) said on tuesday it had issued a warning against a website called ozempen.com for illegally selling...
Boosting local manufacturing: India plans incentives for diabetes, obesity drug makers in 2026 Ruchika Sharma29 Jun 2024 12:57 PM ISTBengaluru: India is set to provide incentives aimed at boosting domestic production of GLP-1 drugs, which are utilized to manage diabetes and...
WHO, Eli Lilly warn against fake versions of popular weight loss, diabetes drugs Ruchika Sharma22 Jun 2024 4:46 PM ISTGeneva: The World Health Organization (WHO) and pharmaceutical company Eli Lilly and Co. are cautioning the public about fake versions of popular...
Biocon quest for partner in China to test generic versions of Novo Nordisk Wegovy, Ozempic Ruchika Sharma21 Jun 2024 3:56 PM ISTShanghai: Biocon is looking for a partner in China to test generic versions of Novo Nordisk's weight loss treatment Wegovy and diabetes...
GLP-1 receptor agonist drugs effective but come with complex concerns shows Research Dr. Kamal Kant Kohli12 Jun 2024 8:45 AM ISTDrugs like Ozempic, Wegovy and Mounjaro have been around for years, but they've recently been making headlines due to a rise in popularity as weight...
Cipla open to collaborate with Eli Lilly to market its obesity drugs in India: CEO Ruchika Sharma11 May 2024 11:30 AM ISTBengaluru: The CEO of Cipla on friday expressed openness to collaborate with U.S. pharmaceutical company Eli Lilly for the marketing of their...
Use of Popular obesity drugs may increase risk of aspiration pneumonia following endoscopy: Study Dr. Kamal Kant Kohli28 March 2024 6:00 AM ISTUse of Popular obesity drugs may increase risk of aspiration pneumonia following endoscopy, suggests new research from Cedars-Sinai. Therefore...
FDA approves semaglutide for major heart disease prevention among obese Dr. Kamal Kant Kohli10 March 2024 9:15 PM ISTThe US Food and Drug Administration (FDA) has approved semaglutide (Wegovy) for reducing risk of cardiovascular death, heart attack, and stroke in...
Novo Nordisk Wegovy gets USFDA nod for lowering heart risks Ruchika Sharma9 March 2024 2:30 PM ISTDenmark: Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved a label expansion for Wegovy based on a...
Cipla, Dr Reddys and other Indian Pharma companies now in race to develop Wegovy versions Ruchika Sharma22 Feb 2024 2:27 PM IST"Dr Reddy's and Cipla are making a copy of the innovator drug more like a generic version, while Sun is working on its own innovator drug. So, Sun...
